RxDoctor Payments Data

Richard Amara, MD

Clinical Cardiac Electrophysiology · Baltimore, MDNPI 1164840518

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.5%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 38.2% of the total. Reporting peaked in 2022 at $3,522 and has fallen 63.6% since, to $1,282 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MD, where the typical reported total is $15,262.

$8,244in general payments, 2019–2025

Across 195 payments — averaging $42.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Medtronic$2K
  • Biosense Webster, Inc.$706
  • Medical Device Business Services, Inc.$553
  • Boston Scientific$453
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$294
  • plus $614 from 9 others

What the payments were for

  • Grants$1,93323%
  • Travel & lodging$1,57219%
  • Food & beverage$4,73957%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,244 in reported general payments places this provider in the 30th percentile of 63 clinical cardiac electrophysiology providers in Maryland.

See all clinical cardiac electrophysiology providers in Maryland

Medicare billing

Part B allowed, 2024
$288,052
Medicare patients
1,241
Services billed
3,627

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban34$51,715
XareltoRivaroxaban12$16,166
FarxigaDapagliflozin Propanediol12$10,225
Metoprolol Succinate84$1,451
Amiodarone Hcl22$1,225
Flecainide Acetate21$1,060
Spironolactone14$170
Metoprolol Tartrate15$68
Losartan Potassium11$46
Amlodipine Besylate18$34

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$184$16,16612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 63 clinical cardiac electrophysiology providers in Maryland.

Other clinical cardiac electrophysiology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →